4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone

C73H93F9N20O13S — CID 161377757

IUPAC4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone
SMILESCC(=O)N1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)CC1.CS(=O)(=O)C1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)C1.O=C1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)CCN1
InChIInChI=1S/C25H32F3N7O4.C24H30F3N7O4.C24H31F3N6O5S/c1-17(36)33-10-12-34(13-11-33)20-8-6-18(7-9-20)14-29-23-21(35(37)38)16-31-24(32-23)30-15-19-4-2-3-5-22(19)39-25(26,27)28;25-24(26,27)38-20-4-2-1-3-17(20)14-30-23-31-15-19(34(36)37)22(32-23)29-13-16-5-7-18(8-6-16)33-11-9-21(35)28-10-12-33;1-39(36,37)19-10-11-32(15-19)18-8-6-16(7-9-18)12-28-22-20(33(34)35)14-30-23(31-22)29-13-17-4-2-3-5-21(17)38-24(25,26)27/h2-5,16,18,20H,6-15H2,1H3,(H2,29,30,31,32);1-4,15-16,18H,5-14H2,(H,28,35)(H2,29,30,31,32);2-5,14,16,18-19H,6-13,15H2,1H3,(H2,28,29,30,31)
InChIKeyVRHLOSMGLAYCJN-UHFFFAOYSA-N
MW1661.72 g/mol
LogP11.70
Rot. Bonds28

About 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone

4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone (PubChem CID 161377757) has the molecular formula C73H93F9N20O13S and a molecular weight of 1661.72 g/mol. Its IUPAC name is 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone.

Molecular Properties

Compound Name4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone
PubChem CID161377757
Molecular FormulaC73H93F9N20O13S
Molecular Weight1661.72 g/mol
Exact Mass1660.68
IUPAC Name4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone
SMILESCC(=O)N1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)CC1.CS(=O)(=O)C1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)C1.O=C1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)CCN1
InChIInChI=1S/C25H32F3N7O4.C24H30F3N7O4.C24H31F3N6O5S/c1-17(36)33-10-12-34(13-11-33)20-8-6-18(7-9-20)14-29-23-21(35(37)38)16-31-24(32-23)30-15-19-4-2-3-5-22(19)39-25(26,27)28;25-24(26,27)38-20-4-2-1-3-17(20)14-30-23-31-15-19(34(36)37)22(32-23)29-13-16-5-7-18(8-6-16)33-11-9-21(35)28-10-12-33;1-39(36,37)19-10-11-32(15-19)18-8-6-16(7-9-18)12-28-22-20(33(34)35)14-30-23(31-22)29-13-17-4-2-3-5-21(17)38-24(25,26)27/h2-5,16,18,20H,6-15H2,1H3,(H2,29,30,31,32);1-4,15-16,18H,5-14H2,(H,28,35)(H2,29,30,31,32);2-5,14,16,18-19H,6-13,15H2,1H3,(H2,28,29,30,31)
InChIKeyVRHLOSMGLAYCJN-UHFFFAOYSA-N
XLogP11.70
TPSA399.90 Ų
H-Bond Donors7
H-Bond Acceptors28
Rotatable Bonds28
Heavy Atoms116
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001661.72
LogP ≤ 511.70
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone?
The IUPAC name of 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone (CID 161377757) is 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone.
What is the SMILES notation for 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone?
The canonical SMILES for 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone is CC(=O)N1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)CC1.CS(=O)(=O)C1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)C1.O=C1CCN(C2CCC(CNc3nc(NCc4ccccc4OC(F)(F)F)ncc3[N+](=O)[O-])CC2)CCN1.
What is the InChIKey of 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone?
The InChIKey is VRHLOSMGLAYCJN-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H32F3N7O4.C24H30F3N7O4.C24H31F3N6O5S/c1-17(36)33-10-12-34(13-11-33)20-8-6-18(7-9-20)14-29-23-21(35(37)38)16-31-24(32-23)30-15-19-4-2-3-5-22(19)39-25(26,27)28;25-24(26,27)38-20-4-2-1-3-17(20)14-30-23-31-15-19(34(36)37)22(32-23)29-13-16-5-7-18(8-6-16)33-11-9-21(35)28-10-12-33;1-39(36,37)19-10-11-32(15-19)18-8-6-16(7-9-18)12-28-22-20(33(34)35)14-30-23(31-22)29-13-17-4-2-3-5-21(17)38-24(25,26)27/h2-5,16,18,20H,6-15H2,1H3,(H2,29,30,31,32);1-4,15-16,18H,5-14H2,(H,28,35)(H2,29,30,31,32);2-5,14,16,18-19H,6-13,15H2,1H3,(H2,28,29,30,31).
What are the key properties of 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone?
4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone has a molecular weight of 1661.72 g/mol, XLogP of 11.70, 28 rotatable bonds, 7 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 4-N-[[4-(3-methylsulfonylpyrrolidin-1-yl)cyclohexyl]methyl]-5-nitro-2-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrimidine-2,4-diamine;1-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]-1,4-diazepan-5-one;1-[4-[4-[[[5-nitro-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]cyclohexyl]piperazin-1-yl]ethanone is sourced from PubChem (CID 161377757), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).